[Interactions between cardiovascular drugs and anesthesia and surgery].
Decisions about chronic treatments during the perioperative period must be made at the presurgical anesthesia consultation. It is increasingly rare to stop treatment during this period, because: This new rule is applied particularly to patients with cardiovascular disorders. Beta blockers have a special role in preventing the onset of postoperative cardiovascular events. The role of statins requires further precision but they appear to fit into the same preventive approach. Interruption of antiplatelet agents appears to be associated with a risk of arterial thrombosis in patients with coronary conditions, notably those with conventional stents and most especially those with drug-eluting stents.
Albaladejo
Pierre
P
Service d'anesthésie-réanimation Samu-Smur 94, Hôpital Henri Mondor, Créteil (94). Electronic address: pierre.albaladejo@hmn.aphp.fr.
Marty
Jean
J
Service d'anesthésie-réanimation Samu-Smur 94, Hôpital Henri Mondor, Créteil (94).
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000758:Anesthesia; D015906:Angioplasty, Balloon, Coronary; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control*; D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D004347:Drug Interactions; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D011945:Receptors, Angiotensin / Q000187:drug effects; D012189:Retrospective Studies; D012307:Risk Factors; D015607:Stents; D013514:Surgical Procedures, Operative; D013927:Thrombosis / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D011945:Receptors, Angiotensin